Lingraphica was founded in 1990 when it first introduced the Lingraphica speech-generating device for adults with aphasia.
The research behind the Lingraphica began thirty years ago with picture cards developed by researchers at the Boston VA Hospital to help people with aphasia communicate. This icon-based language was known as VIC (Visual Communication System) and was followed in the next decade by a computer-based version, CVIC, created by researchers at the Palo Alto VA Hospital. The 1990 Lingraphica realized the dream of turning CVIC into a product for people with aphasia.
In 1995 Lingraphica opened the first of several Language Care Center (LCC) Treatment Programs nationwide. At these centers patients worked on the Lingraphica with a team of specially trained speech-language pathologists. Data from persons enrolled for treatment in these centers documented positive outcomes for both chronic and acute aphasia and are among the largest clinical aphasia studies ever done.
In 2002 Medicare approved the Lingraphica as a speech-generating device whose cost could be reimbursed by insurance. This change opened the way for countless people with aphasia to have their own Lingraphicas.
The designers and programmers of the Lingraphica bring together the latest in technology and rehabilitation as they continue development of the most advanced tool for people with aphasia.
The research behind the Lingraphica began thirty years ago with picture cards developed by researchers at the Boston VA Hospital to help people with aphasia communicate. This icon-based language was known as VIC (Visual Communication System) and was followed in the next decade by a computer-based version, CVIC, created by researchers at the Palo Alto VA Hospital. The 1990 Lingraphica realized the dream of turning CVIC into a product for people with aphasia.
In 1995 Lingraphica opened the first of several Language Care Center (LCC) Treatment Programs nationwide. At these centers patients worked on the Lingraphica with a team of specially trained speech-language pathologists. Data from persons enrolled for treatment in these centers documented positive outcomes for both chronic and acute aphasia and are among the largest clinical aphasia studies ever done.
In 2002 Medicare approved the Lingraphica as a speech-generating device whose cost could be reimbursed by insurance. This change opened the way for countless people with aphasia to have their own Lingraphicas.
The designers and programmers of the Lingraphica bring together the latest in technology and rehabilitation as they continue development of the most advanced tool for people with aphasia.
